BRIEF published on 09/16/2025 at 18:05, 4 months 14 days ago ABIVAX: Distribution of Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 09/16/2025 at 10:04, 4 months 14 days ago JP Morgan Chase exceeds 5% threshold in ABIVAX Capital Actions Abivax Threshold Crossing JP Morgan Chase
BRIEF published on 09/12/2025 at 17:50, 4 months 18 days ago Abivax Joins CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology Abivax SBF 120 CAC Mid 60
PRESS RELEASE published on 09/12/2025 at 17:45, 4 months 18 days ago Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Abivax to join CAC Mid 60 and SBF 120 Indices on Euronext Paris following annual review, enhancing visibility and investor base Euronext Paris Abivax SBF 120 Index Inclusion CAC Mid 60
BRIEF published on 09/08/2025 at 22:05, 4 months 21 days ago Abivax Reports First Half 2025 Financial Performance Financial Results Research And Development Convertible Notes Public Offering Cash Reserves
PRESS RELEASE published on 09/08/2025 at 22:00, 4 months 21 days ago Abivax Presents First Half 2025 Financial Results Abivax presents first half 2025 financial results, revealing operating loss increase and net loss for the period, also updates on clinical programs and public offering Financial Results Abivax Public Offering Clinical Programs Operating Loss
BRIEF published on 09/02/2025 at 11:00, 4 months 28 days ago JP Morgan Chase & Co. Crosses Threshold at ABIVAX Voting Rights Capital Abivax Threshold Crossing JP Morgan
BRIEF published on 08/13/2025 at 18:05, 5 months 17 days ago ABIVAX: Update on capital and voting rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 5 months 17 days ago ABIVAX: Share and voting rights data as of July 31, 2025 Euronext Paris Voting Rights Biotechnology Actions AMF Regulations
BRIEF published on 07/28/2025 at 22:20, 6 months 1 day ago Abivax Completes $747.5 Million Public Offering Biotechnology Abivax Ulcerative Colitis Nasdaq Public Offer
Published on 01/30/2026 at 14:00, 7 hours 31 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 12 hours 56 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 13 hours 31 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 19 hours 16 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 21 hours 31 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 20:10, 1 hour 20 minutes ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 1 hour 21 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 1 hour 23 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 18:31, 2 hours 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/30/2026 at 17:45, 3 hours 46 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 3 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 3 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 3 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
